Biotech · Private company
KBP Biosciences
Track this companyFree. Adds KBP Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials120 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- KBP-5074 0.25 mg tabletPhase 2 · Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- KBP-5074 0.5 mg tabletPhase 2 · Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- KBP-5074Phase 1 · Moderate Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- KBP-5074Phase 1 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- KBP-5074Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- KBP-5074 CapsulePhase 1 · BioequivalenceClinicalTrials.gov · fetched Nov 12, 2026
- KBP-5074 TabletPhase 1 · BioequivalenceClinicalTrials.gov · fetched Nov 12, 2026
- KBP-7072Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- KBP-7072Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Study of KBP-7072 in Healthy Male and Female SubjectsPHASE1 · COMPLETED · started Aug 16, 2022ClinicalTrials.gov NCT05507463 · fetched Nov 12, 2026
- Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)PHASE3 · TERMINATED · started Nov 5, 2021ClinicalTrials.gov NCT04968184 · fetched Nov 12, 2026
- Mass Balance Study of KBP-5074 in Healthy Male SubjectsPHASE1 · COMPLETED · started Dec 3, 2020ClinicalTrials.gov NCT04634812 · fetched Nov 12, 2026
- Drug to Drug Interaction Study of KBP-5074 in Healthy SubjectsPHASE1 · COMPLETED · started Oct 24, 2020ClinicalTrials.gov NCT04606537 · fetched Nov 12, 2026
- Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic ImpairmentPHASE1 · COMPLETED · started Aug 27, 2020ClinicalTrials.gov NCT04534699 · fetched Nov 12, 2026
- A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy SubjectsPHASE1 · COMPLETED · started Aug 11, 2020ClinicalTrials.gov NCT04532957 · fetched Nov 12, 2026
- Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney DiseasePHASE2 · COMPLETED · started Apr 25, 2018ClinicalTrials.gov NCT03574363 · fetched Nov 12, 2026
- Bioavailability of KBP-5074 Tablet vs Capsule FormulationsPHASE1 · COMPLETED · started Oct 26, 2017ClinicalTrials.gov NCT03340753 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney DiseasePHASE1 · COMPLETED · started Jul 13, 2016ClinicalTrials.gov NCT02837237 · fetched Nov 12, 2026
- A Multiple Ascending Dose Study of KBP-7072 in Healthy SubjectsPHASE1 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02654626 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal ImpairmentPHASE1 · COMPLETED · started Jul 29, 2015ClinicalTrials.gov NCT02653014 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacokinetics of KBP-7072PHASE1 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02454361 · fetched Nov 12, 2026